Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

Dry AMD affects part of the eye’s retina that allows for clear central vision.

Study confirms benefit of supplements for slowing age-related

NEI Research News National Eye Institute

Amavita Heart and Vascular HealthTM Raises Awareness about Peripheral Artery Disease - Florida Hospital News and Healthcare Report

News and Events National Eye Institute

Understanding Geographic Atrophy in Advanced Non-Exudative Age-Related Macular Degeneration: a Teaching Case Report

Narrative review of risuteganib for the treatment of dry age

Dry Eye Drugs: New Approaches to an Old Problem

Eleven-year-old Leukemia Patient Rings Bell Celebrating Cancer-Free Diagnosis Following Clinical Trial - Florida Hospital News and Healthcare Report

Age-Related Macular Degeneration (AMD): Non-neovascular and

NIH, National Eye Institute (NEI)

Media Resources Clinical Center Home Page

Inflammation-reducing drug shows no benefit for dry age-related